Marc Schiltz reveals the ambitions of Luxembourg’s National Research Fund (FNR), how his team are encouraging integration and doing far more than just delivering funds to willing researchers.
Over the past 5 years, you have taken it upon yourself to internally reorganize the Luxembourg National Research Fund ( FNR), sharpen its strategic orientation and build bridges with the private sector and the international scientific community. What specific changes have you enacted, and what has been the rationale behind these reforms?
"Luxembourg needs to have a competitive biomedical research sector with international networks thus allowing the nation to achieve global recognition."
